欢迎来到 Antibodies-Online中国区代理商/公司/官网
全国咨询热线: 18327026838
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:15172431432

传真:18372041646

邮箱:sales@amyjet.com

新闻中心
Imanislife logo .png

<

艾美捷科技代理Imanis Life Sciences品牌全系列产品


Imanis Life Sciences是一家专注于再生医学、基因治疗、肿瘤学及溶瘤病毒疗法研究领域的生物技术公司。Imanis Life Sciences科研领域提供两大核心解决方案:溶瘤病毒治疗研究产品:供应用于溶瘤病毒疗法研究的专用病毒制剂;非侵入性影像检测试剂:提供适用于体外及体内研究的全系列试剂,包括报告基因细胞系、报告基因慢病毒载体及特异性抗体。Imanis Life Sciences公司的产品主要包括高品质报告基因细胞系、慢病毒载体及基因构建体、NIS与VSV特异性抗体以及全系列溶瘤病毒资源库。


ImanisLifeSciences页面.png


▍Imanis Life Sciences产品线

● 报告基因慢病毒载体与质粒体系:提供全系列报告基因慢病毒载体及配套质粒解决方案。

即用型病毒载体:安全高效的即用颗粒,适用于原代细胞等难转染细胞类型的报告基因递送(无需额外处理);

病毒包装质粒系统:用于自主制备慢病毒载体颗粒的完整质粒体系。

● 稳定细胞系产品线:提供支持肿瘤学及免疫肿瘤学体内外研究的全系列稳定细胞系。

组成型报告基因细胞系(持续表达):搭载荧光素酶、荧光蛋白或NIS报告基因。应用于体外药物筛选 / 活体动物肿瘤动态监测

肿瘤抗原工程细胞系(靶标调控型):经基因编辑调控常见肿瘤相关抗原及治疗靶点表达水平,核心靶标:CD19、EGFR、Her2

● 溶瘤病毒资源库:提供涵盖即用型病毒储备的完整解决方案,全面助力溶瘤病毒疗法的体内外研究进程。

● 抗体:提供优质的NIS抗体产品,全面兼容免疫印迹(WB)、免疫组化(IHC)、免疫荧光(IF)、流式细胞术,同时推出多功能抗VSV(水泡性口炎病毒)抗体,覆盖WB/IHC/IF/ELISA/流式及VSV中和实验全平台。


▍Imanis Life Sciences部分产品列表


品名规格货号
V-pNIS0.25 mL;1.0 mLLV053S;LV053L
LV-Ub-humanNIS-P2A-Puro0.25 mL;1.0 mLLV038S;LV038L
LV-PGK-humanNIS-P2A-Puro0.25 mL;1.0 mLLV036S;LV036L
LV-humanNIS-P2A-Puro0.25 mL;1.0 mLLV019S;LV019L
LV-humanNIS-IRES-Neo0.25 mL;1.0 mLLV013S;LV013L
LV-humanNIS0.25 mL;1.0 mLLV001S;LV001L
LV-EF1α-humanNIS-P2A-Puro0.25 mL;1.0 mLLV037S;LV037L
LV-CAG-humanNIS-P2A-Puro0.25 mL;1.0 mLLV042S;LV042L
LV-rhesusNIS-PGK-Puro0.25 mL;1.0 mLLV018S;LV018L
LV-rhesusNIS0.25 mL;1.0 mLLV017S;LV017L
LV-EF1α-rhesusNIS-PGK-Puro0.25 mL;1.0 mLLV040S;LV040L
LV-mouseNIS-P2A-Neo0.25 mL;1.0 mLLV025S;LV025L
LV-mouseNIS-PGK-Puro0.25 mL;1.0 mLLV022S;LV022L
Anti-human NIS antibody SJ10.25 mlREA004
Monoclonal anti-human NIS antibody (affinity purified)100 ulREA011
Anti-human (KELE) NIS antibody (affinity purified)100 ulREA010
Anti-human (ETNL) NIS antibody (affinity purified)100 ulREA009
Anti-human NIS antibody clone VJ20.25mLREA003
Anti-human NIS antibody clone VJ10.25mLREA002
Anti-rat NIS antibody (affinity purified)100 ulREA008
Anti-VSV antibody0.25mLREA005



" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Imanis Life Sciences品牌全系列产品">
艾美捷科技代理Imanis Life Sciences品牌全系列产品
...
阅读详情
Logo-R-Website.pngexocell.jpg

艾美捷科技代理Ligatrap品牌全系列产品


LigaTrap Technologies是一家位于北卡罗来纳州的创新型生物技术公司,提供独特的专利技术组合,专注于蛋白质纯化领域。LigaTrap精于抗体与病毒纯化,服务于抗体药物、病毒疫苗及基因治疗产业。


▍LigaTrap公司产品

● LigaGuard:最新推出的亲和吸附剂,是由多模态配体构成的专利复合体系,可在流穿模式(连续流)下选择性捕获宿主细胞蛋白(HCPs)与DNA。

● AAVidity™:一种新型亲和层析填料,用于血清型普适性纯化 源自 HEK293 和 Sf9 细胞裂解液 的 腺相关病毒(AAV)。

● IgM Resin:专为纯化 IgM 抗体设计的亲和树脂,具有高纯度、高结合能力、温和的洗脱条件(pH 约 4.0),并可重复使用多达 100 次。

● Base Resin:专为从多克隆与单克隆来源中纯化高质量抗体而设计,该树脂推荐用于纯化:多种物种的 IgG(包括人、小鼠、兔等);人源 IgA;鸡源 IgY。

● LigaTrap Buffers:包含Regeneration Buffer,Neutralization Buffer,Elution Buffer,Regeneration Buffer,Equilibration/Wash Buffer 2.0等。


Ligatrap.png


▍LigaGuard

LigaGuard™树脂适用于两类核心产品的纯化:蛋白制品:单克隆抗体、生长因子;病毒制品:慢病毒、腺相关病毒(AAV)、病毒疫苗。该树脂的设计使目标生物产物无结合通过,实现高纯度与高回收率。其能清除传统纯化工艺难以去除的高残留性HCPs(HR-HCPs),显著提升终产物的纯度、稳定性、疗效与安全性。

品名货号规格
LigaTrap LigaGuard 1 ml Packed ColumnLT-LG1-1x1mL1mL
LigaTrap LigaGuard 5ml Packed ColumnLT-LG1-1x5mL5mL
LigaTrap LigaGuard Loose Resin - 5mLLT-LG15 mL
LigaTrap LigaGuard Loose Resin - 10mLLT-LG1-10mL10 mL
LigaTrap LigaGuard Loose Resin - 25mLLT-LG1-25mL25 mL
LigaTrap LigaGuard Loose Resin - 50mLLT-LG1-50mL50 mL
LigaTrap LigaGuard Loose Resin - 100mLLT-LG1-100mL100 mL


▍AAVidity

AAVidity填料通过合成亲和配体功能化修饰,可捕获所有血清型的 AAV,提供卓越的结合载量与污染物(宿主细胞蛋白 HCPs 及宿主细胞DNA hcDNA清除能力。其温和洗脱条件在保障 AAV 转导活性的同时,实现高产物回收率。

品名货号规格
LigaTrap AAVidity Loose Resin – 1mLLT-AAV-1mL1mL
LigaTrap AAVidity Loose Resin – 5mLLT-AAV-5mL5mL
LigaTrap AAVidity Prepacked Column – 1mLLT-AAV-1x1mL1x1mL
LigaTrap AAVidity Prepacked Column – 5mLLT-AAV-1x5mL1x5mL


▍IgM Resin

 IgM纯化树脂的核心优势包括:

● 全面捕获:同时结合IgM的重链与轻链亚型;

● 零风险:无免疫原性及配体脱落;

● 活性保全:温和洗脱条件保障抗体完整性;

● 经济耐用:消毒再生后可重复使用 ≥100 次;

● 该树脂能高效处理并纯化来自以下样本的单克隆 IgM:细胞培养上清,腹水,杂交瘤,其他重组 IgM 来源。

品名货号规格
IgM Microspin Column Kit w/ BuffersLT-155KITKIT-10x0.1mL
IgM 1mL Prepacked Column Kit w/ BuffersLT-155-1mL KITKIT-1x1mL
IgM 5mL Prepacked Column Kit w/ BuffersLT-155-5mL KITKIT-1x5mL
IgM Loose Resin – 5mLLT-1555mL
IgM Loose Resin – 10mLLT-155-10mL10mL
IgM Loose Resin – 25mLLT-155-25mL25mL
IgM Loose Resin – 50mLLT-155-50mL50mL
IgM Loose Resin – 100mLLT-155-100mL100mL
IgM Microspin Columns without BuffersLT-155-MSC10x0.1mL
IgM Prepacked Column – 1mLLT-155-1x1mL1x1mL
IgM Prepacked Column – 5mLLT-155-1x5mL1x5mL
IgM Prepacked Columns – 3x1mLLT-155-3x1mL3x1mL

▍Base Resin

LigaTrap基础纯化树脂可实现高回收率与>95%的纯度,而传统Protein A和Protein G填料的回收率甚至低于检测限。通过优化工艺,该树脂的纯度可进一步提升至99%。

品名货号规格
Base Resin Microspin Column Kit w/ BuffersLT-150KITKIT-10x0.1mL
Base Resin 1mL Prepacked Column Kit w/ BuffersLT-150-1mL KITKIT-1x1mL
Base Resin 5mL Prepacked Column Kit w/ BuffersLT-150-5mL KITKIT-1x5mL
Loose Base Resin – 5mLLT-1505mL
Loose Base Resin – 10mLLT-150-10mL10mL
Loose Base Resin – 25mLLT-150-25mL25mL
Loose Base Resin – 50mLLT-150-50mL50mL
Loose Base Resin – 100mLLT-150-100mL100mL
Base Resin Microspin Columns without BuffersLT-150-MSC10x0.1mL
Base Resin Prepacked Column – 1mLLT-150-1x1mL1x1mL
Base Resin Prepacked Column – 5mLLT-150-1x5mL1x5mL
Base Resin Prepacked Columns – 3x1mLLT-150-3x1mL3x1mL


▍Buffers

品名货号规格
LigaTrap Elution BufferBU-123-FP125ml
LigaTrap Regeneration BufferBU-124-FP50ml
LigaTrap Neutralization BufferBU-125-FP15ml
LigaTrap Storage BufferBU-126-FP50 ml
LigaTrap Sample Diluent 2.0BU-131-FP15 ml
LigaTrap Equilibration/Wash Buffer 2.0BU-132-FP250ml
LigaTrap IgM Elution Buffer pH 3.8BU-133-FP125 ml
LigaTrap Elution BufferBU-123-500-FP500ml
LigaTrap Regeneration BufferBU-124-500-FP500 ml
LigaTrap Neutralization BufferBU-125-250-FP250 ml
LigaTrap Storage BufferBU-126-500-FP500 ml
LigaTrap Sample Diluent 2.0BU-131-250-FP250 ml
LigaTrap Equilibration/Wash Buffer 2.0BU-132-1-FP1L
LigaTrap IgM Elution Buffer pH 3.8BU-133-500-FP500ml


" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Ligatrap品牌全系列产品">
艾美捷科技代理Ligatrap品牌全系列产品
...
阅读详情
logo.jpg

<

艾美捷科技代理Helvetica Health Care品牌全系列产品


Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员,Helvetica Health Care通过了ISO 13485认证,在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板,适用于不同的分子测试平台和检测。这些产品有多种规格,可用于单一或多种分析物的检测,帮助实验室监控测试性能,确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制,满足不同平台的需求。


▎Helvetica Health Care产品线

Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。


HelveticaHealthCare页面.png


▎Helvetica Health Care部分产品列表


货号产品描述
NATFRC-6CNATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL)
NATCV9-6CNATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL)
NATRPC2.1-BIONATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL)
NATRVP2.1-BIONATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA)
NATRVP2.1-BIO PlusNATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml)
NATRVP2-QIANATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA)
NATSARS(COV2)-VPNATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL)
NATSARS(COV2)-ERCSARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)
NATSARS(COV2)-ERC1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml)
NATSARS(COV2)-NEGSARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL)
NATSARS(COV2)-NEG1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml)
NATSARS(COV2)-STSARS-Related Coronavirus 2 (SARS-CoV-2) Stock
NATSARS(COV2-SA)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)
NATSARS(COV2-UK)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL)
0810229-0.5mgCoronavirus 229E Lysate (0.5 mg)
0810587SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg)
0810587-0.5mgSARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg)
0810587CFHI-0.5mLSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL)
0810587CFHISARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL)
0810587UVSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL)
0810589CFHISARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL)
0810589UVSARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL)
0810590CFHISARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810590UVSARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL)
0810617UVSARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV))
0810618UVSARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV)
0810619UVSARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810620UVSARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810621UVSARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated)
0810622UVSARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated)
0810612CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810612UVSARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL)
0810613CFHISARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL)
0810613UVSARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL)
0810614CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810614UVSARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL)
0810616CFHISARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL)
0810616UVSARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL)
0810617CFHISARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml)
0810618CFHISARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml)
0810619CFHISARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810620CFHISARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810621CFHISARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml)
0810622CFHISARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml)
0810623UVSARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated)
0810623CFHISARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated)
0810624UVSARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated)
0810624CFHISARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated)
0820010CFHIVeroE6 Culture Fluid (Heat Inactivated) (1 mL)
0801043Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml)
0831042SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL)
0831043SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL)
NATSARS-STCoronavirus SARS Stock (Qualitative) (1 mL)
NATCOV(229E)-STCoronavirus 229E Stock (Qualitative) (1 mL)
0810229CFHICoronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL)
0810229Coronavirus Strain: 229E Lysate
0810229UVCoronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(NL63)-STCoronavirus NL63 Stock (Qualitative) (1 mL)
0810228CFHICoronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL)
0810228Coronavirus Strain: NL63 Lysate
0810228UVCoronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(OC43)-STCoronavirus OC43 Stock (Qualitative) (1 mL)
0810024CFHICoronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL)
0810024Coronavirus Strain: OC43 Lysate
NATMERS-STMERS-CoV Stock (Qualitative) (1 mL)
NATMR-BIONATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml)
NATCOV(MR)-BIONATtrol MERS-S. Cerevisiae (0.6 ml)
0810575MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg)
0810575-0.5mgMERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg)
CV033122COVID-19 Cross Over Panel (40x 1.0 ml)




" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Helvetica Health Care品牌全系列产品">
艾美捷科技代理Helvetica Health Care品牌全系列产品
...
阅读详情
Megazyme-by-Neogen_Logo.jpgexocell.jpg

<

艾美捷科技代理MegaZyme品牌


Megazyme 成立于1988年,位于爱尔兰,是一家全球知名的酶及酶法分析试剂盒的生产厂家,专注于制造和供应高品质和创新的检测试剂盒和生化分析试剂。Megazyme 产品线以其卓越的高纯度酶制剂而闻名,是全球多种碳水化合物及酶底物产品的核心供应商。该公司目前提供了超过70种诊断试剂盒和超过300种其他试剂和底物。


Megazyme产品广泛应用的领域:

1)食品和饮料‌:用于检测和分析食品中的成分和添加剂。

2)生物燃料‌:用于生物燃料的开发和生产过程中的质量控制。

3)动物饲料‌:确保饲料成分的安全和营养价值。

4)葡萄酒和酿造‌:用于葡萄酒的发酵和质量控制。

5)乳制品和谷类食品‌:用于乳制品和谷类食品的营养成分分析。


正文图.png


Megazyme产品线包括:

● 检测试剂盒:涵盖膳食纤维、淀粉、糖类、醇类、有机酸、酶活性等领域;

● 高纯度酶制剂与生化底物:生产供应种类繁多的高纯度酶,包括:碳水化合物水解酶、氧化还原酶、蛋白酶 & 脂肪酶以及其他特异性酶。此外,Megazyme还提供各种高纯度的酶作用底物,特别是碳水化合物底物;

● 分析标准品与参比物质:提供与检测试剂盒配套或独立的高纯度、认证的分析标准品,包括分析标准缓冲液,辅助因子与染色剂等;

● 配套仪器与自动化解决方案:Megazyme 也开发或整合了部分专用仪器,用于高通量处理特定检测 (如膳食纤维) 中的复杂步骤。


" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理MegaZyme全系列产品">
艾美捷科技代理MegaZyme全系列产品
...
阅读详情
logo.jpg

<

艾美捷科技代理Helvetica Health Care品牌全系列产品


Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员,Helvetica Health Care通过了ISO 13485认证,在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板,适用于不同的分子测试平台和检测。这些产品有多种规格,可用于单一或多种分析物的检测,帮助实验室监控测试性能,确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制,满足不同平台的需求。


▎Helvetica Health Care产品线

Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。


HelveticaHealthCare页面.png


▎Helvetica Health Care部分产品列表


货号产品描述
NATFRC-6CNATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL)
NATCV9-6CNATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL)
NATRPC2.1-BIONATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL)
NATRVP2.1-BIONATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA)
NATRVP2.1-BIO PlusNATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml)
NATRVP2-QIANATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA)
NATSARS(COV2)-VPNATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL)
NATSARS(COV2)-ERCSARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)
NATSARS(COV2)-ERC1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml)
NATSARS(COV2)-NEGSARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL)
NATSARS(COV2)-NEG1NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml)
NATSARS(COV2)-STSARS-Related Coronavirus 2 (SARS-CoV-2) Stock
NATSARS(COV2-SA)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL)
NATSARS(COV2-UK)-STNATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL)
0810229-0.5mgCoronavirus 229E Lysate (0.5 mg)
0810587SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg)
0810587-0.5mgSARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg)
0810587CFHI-0.5mLSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL)
0810587CFHISARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL)
0810587UVSARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL)
0810589CFHISARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL)
0810589UVSARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL)
0810590CFHISARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810590UVSARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL)
0810617UVSARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV))
0810618UVSARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV)
0810619UVSARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810620UVSARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated)
0810621UVSARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated)
0810622UVSARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated)
0810612CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810612UVSARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL)
0810613CFHISARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL)
0810613UVSARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL)
0810614CFHISARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL)
0810614UVSARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL)
0810616CFHISARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL)
0810616UVSARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL)
0810617CFHISARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml)
0810618CFHISARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml)
0810619CFHISARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810620CFHISARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml)
0810621CFHISARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml)
0810622CFHISARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml)
0810623UVSARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated)
0810623CFHISARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated)
0810624UVSARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated)
0810624CFHISARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated)
0820010CFHIVeroE6 Culture Fluid (Heat Inactivated) (1 mL)
0801043Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml)
0831042SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL)
0831043SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL)
NATSARS-STCoronavirus SARS Stock (Qualitative) (1 mL)
NATCOV(229E)-STCoronavirus 229E Stock (Qualitative) (1 mL)
0810229CFHICoronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL)
0810229Coronavirus Strain: 229E Lysate
0810229UVCoronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(NL63)-STCoronavirus NL63 Stock (Qualitative) (1 mL)
0810228CFHICoronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL)
0810228Coronavirus Strain: NL63 Lysate
0810228UVCoronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL)
NATCOV(OC43)-STCoronavirus OC43 Stock (Qualitative) (1 mL)
0810024CFHICoronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL)
0810024Coronavirus Strain: OC43 Lysate
NATMERS-STMERS-CoV Stock (Qualitative) (1 mL)
NATMR-BIONATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml)
NATCOV(MR)-BIONATtrol MERS-S. Cerevisiae (0.6 ml)
0810575MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg)
0810575-0.5mgMERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg)
CV033122COVID-19 Cross Over Panel (40x 1.0 ml)




" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Helvetica Health Care品牌全系列产品">
艾美捷科技代理Helvetica Health Care品牌全系列产品
...
阅读详情
logo.png

<

艾美捷科技代理Aneufast品牌全系列产品


Aneufast是一家专业生产诊断非整倍体染色体试剂盒的生物公司。QF-PCR试剂盒Aneufast公司的核心产品。Aneufast™ QF-PCR试剂盒包含六组多重标记系统,基于短串联重复序列(STRs)扩增技术,可同步检测精选微卫星位点及性别决定基因(Amelogenin-SRY)。该设计通过单次反应实现多染色体同步筛查,显著提升检测效率。此标记组合可精准识别13、18、21号常染色体及X、Y性染色体的非整倍体异常。


Aneufast页面.png


Aneufast™ QF-PCR试剂盒具有以下特点:

● 五色荧光DNA片段分析系统:采用五重荧光标记技术,实现单次电泳中13/18/21/X/Y染色体STR标记的同步检测与区分;

● 即用型PCR预混体系:含热启动聚合酶及优化缓冲液,操作仅需 "加DNA→扩增" 两步;

● 超快速检测流程:样本到结果仅需3.5小时

● 染色体特定位点备份设计:每套试剂盒额外提供 13/18/21/X/Y染色体专属STR标记(独立分装)

● 全平台兼容性:经优化适配ABI全系列基因分析仪,如3500/3500xL Dx,SeqStudio Flex和7500 Fast Dx

● 国际质量认证:符合欧盟体外诊断指令98/79/EC;通过 ISO 9001:2000 及 ISO 13485:2003 医疗器械生产双认证



" data-original="http://antibodie.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Aneufast品牌全系列产品">
艾美捷科技代理Aneufast品牌全系列产品
...
阅读详情

Copyright © 2026 Powered by Antibodies-Online中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap